Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.93 USD | -4.27% | -2.95% | -61.71% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 10.98M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -31M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-0.72
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.52% |
Latest transcript on Moleculin Biotech, Inc.
1 day | -4.27% | ||
1 week | -2.95% | ||
Current month | -1.79% | ||
1 month | +6.48% | ||
3 months | -44.20% | ||
6 months | -41.41% | ||
Current year | -61.71% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 15-07-27 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 16-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Michael Cannon
BRD | Director/Board Member | 78 | 15-06-30 |
John Climaco
BRD | Director/Board Member | 55 | 17-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 4.93 | -4.27% | 16,669 |
24-05-23 | 5.15 | +1.38% | 7,232 |
24-05-22 | 5.08 | +2.42% | 12,920 |
24-05-21 | 4.96 | +0.20% | 24,044 |
24-05-20 | 4.95 | -2.56% | 13,982 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.71% | 10.98M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.25% | 21.78B | |
-8.98% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- MBRX Stock